A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 75.20
+0.30 (0.40%)
Sep 18, 2026, 1:30 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.55 billion as of September 17, 2026. Its market cap has decreased by -19.59% in one year.
Market Cap
2.55B
Enterprise Value
2.24B
Revenue
887.93M
Ranking
n/a
PE Ratio
13.87
Stock Price
75.20
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.55B, an increase of 67.50%. That is a compound annual growth rate of 14.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.55B | -13.66% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.34B |
| Apex Biotechnology | 2.99B |
| Bonraybio | 2.97B |
| Applied BioCode | 2.79B |
| Wellell | 2.46B |
| Dynamic Medical Technologies | 2.15B |
| Medimaging Integrated Solution | 2.05B |
| OK Biotech | 2.02B |